F
Fabien Zoulim
Researcher at French Institute of Health and Medical Research
Publications - 716
Citations - 40988
Fabien Zoulim is an academic researcher from French Institute of Health and Medical Research. The author has contributed to research in topics: Hepatitis B virus & Hepatitis B. The author has an hindex of 96, co-authored 641 publications receiving 35807 citations. Previous affiliations of Fabien Zoulim include Hotel Dieu Hospital & University of Orléans.
Papers
More filters
Journal ArticleDOI
559 An overview of biochemical markers (fibrotest-actitest) diagnostic value in chronic liver diseases: A non-invasive alternative to liver biopsy
Thierry Poynard,Françoise Imbert-Bismut,V. Ratziu,Sylvie Naveau,Dominique Thabut,Didier Lebrec,Philippe Halfon,Fabien Zoulim,M. Bourlière,Djamila Messous +9 more
Journal ArticleDOI
Possible prevention of chronic hepatitis B by early interferon therapy.
Christian Trepo,Isabelle Chemin,Marie-Anne Petit,P. Chossegros,Fabien Zoulim,Philippe Chevallier,M. Sepetjan +6 more
TL;DR: The results suggest that interferon treatment of patients with prolonged hepatitis B infection may prevent progression to chronicity, and should trigger more vigilant screening for patients with raised serum transaminase levels and viral markers of hepatitis B infections.
Journal ArticleDOI
New Recommendations of Baveno Vi Conference for the Screening of Portal Hypertension: An Independent Sequential Validation in Patients with Compensated Viral Cirrhosis Taking into Account Virological Status (Anrs Co12 Cirvir Cohort)
Dominique Thabut,C. Bureau,Richard Layese,V. Bourcier,L. Corvy,Ventzislava Petrov-Sanchez,Patrick Marcellin,Dominique Guyader,Stanislas Pol,Dominique Larrey,Fabien Zoulim,Dominique Roulot,V. de Ledinghen,Denis Ouzan,A. Tran,Jean-Pierre Bronowicki,Ghassan Riachi,Paul Calès,Jean-Marie Péron,Laurent Alric,M. Bourlière,P. Mathurin,Jean-Pierre Zarski,P. Roudot-Thorava,P. Nahon +24 more
Journal ArticleDOI
Auto-immunisation induite par l’interféron alpha dans un contexte d’hépatite virale C chronique
TL;DR: In this paper, a femme de 56 ans, presentant une hepatite C chronique post-transfusionnelle, who a presente sous traitement antiviral par interferon alpha-2b, une poussee cytolytique associee a une evolution rapidement fibrosante de la maladie hepatique.
Journal ArticleDOI
Design and Evaluation of Hepatitis B Virus Inhibitors
TL;DR: The design of new nucleoside analogs that inhibit hepatitis B virus replication allowed their evaluation in in vitro and in vivo experimental models of HBV infection and led to the discovery of the anti-HBV activity of lamivudine and its approval for the therapy of chronic hepatitis B.